Evidence map›Paper›PMID 37148904›Full record

ReviewThe Lancet. Infectious diseases2023

Infectious diseases in Indigenous populations in North America: learning from the past to create a more equitable future.

Naomi R Lee, Alexandra King, Deionna Vigil, Dustin Mullaney, Priscilla R Sanderson, Taiwo Ametepee, Laura L Hammitt

Open access · bronzeAbstract readReview
In one paragraph

Review in The Lancet. Infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Understanding Community Perspectives onInternational journal of environmental research and public health · 2026
    Article
  3. Article
  4. Toward Relationality in Infectious Disease Research.Open forum infectious diseases · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Naomi R LeeDepartment of Chemistry and Biochemistry, Northern Arizona University, Flagstaff, AZ, USA.
Alexandra KingCollege of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Deionna VigilDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Dustin MullaneyDepartment of Biology, Northern Arizona University, Flagstaff, AZ, USA.
Priscilla R SandersonDepartment of Health Sciences, College of Health and Human Services, Northern Arizona University, Flagstaff, AZ, USA.
Taiwo AmetepeeCollege of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Laura L HammittDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: lhammitt@jhu.edu.
Northern Arizona University · USJohns Hopkins University · USUniversity of Saskatchewan · CA

Funding

SSCIMA: Integrating Analysis of Socio-economic Sub-population Dynamics to Improve Spatial Models of Infectious DiseaseU54MD012388 · NIMHD · NORTHERN ARIZONA UNIVERSITY · PI Julie A. Baldwin · 2017 to 2026
$49.7M
Training/Career Development and Education Core and PlansU54CA143925 · NCI · NORTHERN ARIZONA UNIVERSITY · PI Jason A Wilder · 2009 to 2026
$27.5M
Uranium as an Environmental Risk Factor for Cancer Among the NavajoU54CA143924 · NCI · UNIVERSITY OF ARIZONA · PI Jennifer Wright Bea · 2009 to 2026
$26.7M
NCI NIH HHS U54 CA143924NCI NIH HHS U54 CA143925NIMHD NIH HHS U54 MD012388
6 · The paper itself

Abstract

The COVID-19 pandemic, although a profound reminder of endured injustices by and the disparate impact of infectious diseases on Indigenous populations, has also served as an example of Indigenous strength and the ability to thrive anew. Many infectious diseases share common risk factors that are directly tied to the ongoing effects of colonisation. We provide historical context and case studies that illustrate both challenges and successes related to infectious disease mitigation in Indigenous populations in the USA and Canada. Infectious disease disparities, driven by persistent inequities in socioeconomic determinants of health, underscore the urgent need for action. We call on governments, public health leaders, industry representatives, and researchers to reject harmful research practices and to adopt a framework for achieving sustainable improvements in the health of Indigenous people that is both adequately resourced and grounded in respect for tribal sovereignty and Indigenous knowledge.

Indexed as

Communicable DiseasesCOVID-19CanadaHumansIndigenous PeoplesNorth AmericaPandemics

Identifiers

PMID37148904
PMCPMC10156139
OpenAlexW4367836284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.